STUDY SEARCH RESULTS

1 study found for your search request:  7902-013

A Study of Lenvatinib (MK-7902) in Pediatric Participants with Relapsed or Refractory Solid Malignan...
Condition: Relapsed or Refractory Solid Tumors
Minimum Age: 2 years, Maximum Age: 21 years
Gender: All
Study ID: NCT04447755
Status: Active, not recruiting




Copyright © 2024 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  U.S. Corporate Site